Abstract
Jun : Fos and Jun : ATF complexes represent two classes of AP-1 dimers that (1) preferentially bind to either heptameric or octameric AP-1 binding sites, and (2) are differently regulated by cellular signaling pathways and oncogene products. To discriminate between the functions of Jun : Fos, Jun : ATF and Jun : Jun, mutants were developed that restrict the ability of Jun to dimerize either to itself, or to Fos(-like) or ATF(-like) partners. Introduction of these mutants in chicken embryo fibroblasts shows that Jun : Fra2 and Jun : ATF2 dimers play distinct, complementary roles in in vitro oncogenesis by inducing either anchorage independence or growth factor independence, respectively. v-Jun : ATF2 rather than v-Jun : Fra2 triggers the development of primary fibrosarcomas in the chicken wing. Genes encoding extracellular matrix components seem to constitute an important subset of v-Jun : ATF2-target genes. Repression of the matrix component SPARC by Jun is essential for the induction of fibrosarcomas. Avian primary cells transformed by either Jun : Fra2 or Jun : ATF2 thus provide powerful tools for the investigation of the downstream pathways involved in oncogenesis. Further genetic studies with Jun dimerization mutants will be required to be precise and extend the specific roles of the Jun : Fos and Jun : ATF dimers during cancer progression in avian and mammalian systems.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Angel P, Hattori K, Smeal T, Karin M . 1988 Cell 55: 875–885
Angel P, Karin M . 1991 Biochim. Biophys. Acta 1072: 129–157
Bar-Sagi, D, Hall A . 2000 Cell 103: 227–238
Battista S, de Nigris F, Fedele M, Chiappetta G, Scala S, Vallone D, Pierantoni G, Mega T, Santoro M, Viglietto G, Verde P, Fusco A . 1998 Oncogene 17: 377–385
Baxevanis A, Vinson C . 1993 Curr. Opin. Genet. and Dev. 3: 278–285
Behrens A, Jochum W, Sibilia M, Wagner E . 2000 Oncogene 19: 2657–2663
Benbrook D, Jones N . 1994 Nucleic Acids Res. 22: 1463–1469
Benbrook DM, Jones NC . 1990 Oncogene 5: 295–302
Benjamin T, Vogt PK . 1990 Virology, Vol. 1. Fields NB. (ed.). DM Knipe et al Raven Press, Ltd.: New York pp. 317–367
Benkhelifa S, Provot S, Lecoq O, Pouponnot C, Calothy G, Felder-Schmittbuhl M-P . 1998 Oncogene 17: 247–254
Bergers G, Graninger P, Braselmann S, Wrighton C, Busslinger M . 1995 Mol. Cell. Biol. 15: 3748–3758
Binetruy B, Smeal T, Karin M . 1991 Nature 351: 122–127
Bos T, Margiotta P, Bush L, Wasilenko W . 1999 Int. J. Cancer 81: 404–410
Bos TJ, Monteclaro FS, Mitsunobu F, Ball AR, Chang CHW, Nishimura T, Vogt PK . 1990 Genes Dev. 4: 1677–1687
Buchou T, Kranenburg O, van Dam H, Roelen D, Zantema A, Hall F, van der Eb A . 1993 Oncogene 8: 1765–1773
Castellazzi M, Dangy JP, Mechta F, Hirai SI, Yaniv M, Samarut J, Lassailly A, Brun G . 1990 Oncogene 5: 1541–1547
Castellazzi M, Loiseau L, Piu F, Sergeant A . 1993 Oncogene 8: 1149–1160
Castellazzi M, Spyrou G, La Vista N, Dangy J, Piu F, Yaniv M, Brun G . 1991 Proc. Natl. Acad. Sci. USA 88: 8890–8894
Chatton B, Bocco J, Goetz J, Gaire M, Lutz Y, Kedinger C . 1994 Oncogene 9: 375–385
Chen L, Glover J, Hogan P, Rao A, Harrison S . 1998 Nature 392: 42–48
Chiariello M, Marinissen M, Gutkind J . 2000 Mol. Cell. Biol. 20: 1747–1758
Chiu R, Boyle W, Meek J, Smeal T, Hunter T, Karin M . 1988 Cell 54: 541–552
Claret F, Hibi M, Dhut S, Toda T, Karin M . 1996 Nature 383: 453–457
Clark W, Black E, MacLaren A, Kruse U, LaThangue N, Vogt P, Gillespie D . 2000 Mol. Cell. Biol. 20: 2529–2542
Cook S, Aziz N, McMahon M . 1999 Mol. Cell. Biol. 19: 330–341
Davis R . 1999 Biochem. Soc. Symp. 64: 1–12
de Ruiter N, Wolthuis R, van Dam H, Burgering B, Bos J . 2000 Mol. Cell. Biol. 20: 8480–8488
Duyndam M, van Dam H, Smits P, Verlaan M, van der Eb A, Zantema A . 1999 Oncogene 18: 2311–2321
Duyndam M, van Dam H, van der Eb A, Zantema A . 1996 J. Virol. 70: 5852–5859
Falvo J, Parekh B, Lin C, Fraenkel E, Maniatis T . 2000 Mol. Cell. Biol. 20: 4814–4825
Flint KJ, Jones NC . 1991 Oncogene 6: 2019–2026
Fu S, Bottoli I, Goller M, Vogt P . 1999 Proc. Natl. Acad. Sci. USA 96: 5716–5721
Gao M, Morgan I, Vogt P . 1996 Cancer Res. 56: 4229–4235
Glover JNM, Harrison SC . 1995 Nature 373: 257–261
Goller ME, Iacovoni JS, Vogt PK, Kruse U . 1998 Oncogene 16: 2945–2948
Hadman M, Gabos L, Loo M, Sehgal A, Bos T . 1996 Oncogene 12: 135–142
Hagmeyer B, Angel P, van Dam H . 1995 BioEssays 17: 621–629
Hagmeyer B, Duyndam M, Angel P, de Groot R, Verlaan M, Elfferich P, van der Eb A, Zantema A . 1996 Oncogene 12: 1025–1032
Hai T, Curran T . 1991 Proc. Natl. Acad. Sci. USA 88: 3720–3724
Hai T, Liu F, Coukos W, Green M . 1989 Genes Dev. 3: 2083–2090
Hai T, Wolfgang C, Marsee D, Allen A, Sivaprasad U . 1999 Gene Exp. 7: 321–335
Hanahan D, Weinberg R . 2000 Cell 100: 57–70
Hartl M, Bister K . 1995 Proc. Natl. Acad. Sci. USA 92: 1131–1135
Hartl M, Bister K . 1998 Oncogene 17: 2901–2913
Hartl M, Vogt PK . 1992a Cell Growth Differ. 3: 899–908
Hartl M, Vogt PK . 1992b Cell Growth Differ. 3: 909–918
Havarstein LS, Morgan IM, Wong WY, Vogt PK . 1992 Proc. Natl. Acad. Sci. USA 89: 618–622
Hennigan R, Hawker K, Ozanne B . 1994 Oncogene 9: 3591–3600
Hernandez-Munoz I, Malumbres M, Leonardi P, Pellicer A . 2000 Oncogene 19: 2745–2757
Hofmann M, Rudy W, Günthert U, Zimmer SG, Zawadzki V, Zoller M, Lichtner RB, Herrlich P, Ponta H . 1993 Cancer Res. 53: 1516–1521
Hsu J, Laz T, Mohn K, Taub R . 1991 Proc. Natl. Acad. Sci. USA 88: 3511–3515
Hughes M, Sehgal A, Hadman M, Bos T . 1992 Cell Growth Differ. 3: 889–897
Huguier S, Baguet J, Perez S, van Dam H, Castellazzi M . 1998 Mol. Cell. Biol. 18: 7020–7029
Iba H, Shindo Y, Nishina H, Yoshida T . 1988 Oncogene Res. 2: 121–133
Ito T, Yamauchi M, Nishina M, Yamamichi N, Mizutani T, Ui M, Murakami M, Iba H . 2001 J. Biol. Chem. 276: 1852–1857
Ivashkiv L, Liou H, Kara C, Lamph W, Verma I, Glimcher L . 1990 Mol. Cell. Biol. 10: 1609–1621
Jain J, McCaffrey P, Miner Z, Kerppola T, Lambert J, Verdine G, Curran T, Rao A . 1993 Nature 365: 352–355
Johnson R, Spiegelman B, Hanahan D, Wisdom R . 1996 Mol. Cell. Biol. 16: 4504–4511
Jove R, Hanafusa H . 1987 Annu. Rev. Cell Biol. 3: 31–56
Jurdic P, Treilleux I, Vandel L, Tabone E, Huguier S, Sergeant A, Castellazzi M . 1995 Oncogene 11: 1699–1709
Kageyama R, Sasai Y, Nakanishi S . 1991 J. Biol. Chem. 266: 15525–15531
Karin M, Liu Z-G, Zandi E . 1997 Cur. Opin. Cell Biol. 9: 240–246
Kataoka K, Nishizawa M, Kawai S . 1993 J. Virol. 67: 2133–2141
Kawasaki H, Schiltz L, Chiu R, Itakura K, Taira K, Nakatani Y, Yokoyama K . 2000 Nature 405: 195–200
Kawasaki HSJ, Eckner R, Ugai H, Chiu R, Taira K, Shi Y, Jones N, Yokoyama KK . 1998 Genes Dev. 12: 233–245
Kerpola T, Curran T . 1996 Oncogene 9: 675–684
Kilbey A, Black E, Unlu M, Gillespie D . 1996 Oncogene 12: 2409–2418
Kim D, LaQuaglia MP, Yang SY . 1996 Biochim. Biophys. Acta 1309: 183–188
Konig H, Ponta H, Rahmsdorf U, Buscher M, Schontal A, Rahmsdorf H, Herrlich P . 1989 EMBO J. 8: 2559–2566
Lamb R, Hennigan R, Turnbull K, Katsanakis K, Mac Kenzie E, Birnie G, Ozanne B . 1997 Mol. Cell. Biol. 17: 963–976
Lee J, See R, Deng T, Shi Y . 1996 Mol. Cell. Biol. 16: 4312–4326
Li X-Y, Green MR . 1996 Genes Dev. 10: 517–527
Liang G, Wolfgang C, Chen B, Chen T, Hai T . 1996 J. Biol. Chem. 271: 1695–1701
Liberati N, Datto M, Frederick J, Shen F, Wong C, Rougier-Chapman E, Wang X . 1999 Proc. Natl. Acad. Sci. USA 96: 4844–4849
Liu F, Green M . 1990 Cell 61: 1217–1224
Lloyd A, Yancheva N, Wasylyck B . 1991 Nature 352: 635–638
Maki Y, Bos TJ, Davis C, Starbuck M, Vogt PK . 1987 Proc. Natl. Acad. Sci. USA 84: 2848–2852
Matsuo K, Owens J, Tonko M, Elliott C, Chambers T, Wagner E . 2000 Nature Genetics 24: 184–187
McCarthy SA, Chen D, Yang BS, Garcia Ramirez JJ, Cherwinski H, Chen XR, Klagsbrun M, Hauser CA, Ostrowski MC, McMahon M . 1997 Mol. Cell. Biol. 17: 2401–2412
Mechta F, Lallemand D, Pfarr C, Yaniv M . 1997 Oncogene 14: 837–847
Mettouchi A, Cabon F, Montreau N, Dejong V, Vernier P, Gherzi R, Mercier G, Binetruy B . 1997 Mol. Cell. Biol. 17: 3202–3209
Mettouchi A, Cabon F, Montreau N, Vernier P, Mercier G, Blangy D, Tricoire H, Vigier P, Binetruy B . 1994 EMBO J. 13: 5668–5678
Morgan I, Havarstein L, Wong W, Luu P, Vogt P . 1994 Oncogene 9: 2793–2797
Morgan I, Ransone L, Bos T, Verma I, Vogt P . 1992 Oncogene 7: 1119–1125
Motohashi H, Shavit J, Igarashi K, Yamamoto M, Engel J . 1997 Nucleic Acids Res. 25: 2953–2959
Muramaki M, Sonobe M, Ui M, Kabuyama Y, Watanabe H, Wada T, Handa H, Iba H . 1997 Oncogene 14: 2435–2444
Musti A, Treier M, Bophmann D . 1997 Science 275: 400–402
Nishina H, Sato H, Suzuki T, Sato M, Iba H . 1990 Proc. Natl. Acad. Sci. USA 87: 3619–3623
Nishizawa M, Kataoka K, Goto N, Fujiwara . 1989 Proc. Natl. Acad. Sci. USA 86: 7711–7715
O'Neil K, Hoess R, DeGrado W . 1990 Science 249: 774–778
O'Shea EK, Rutkowski R, Kim PS . 1992 Cell 68: 699–708
Oliviero S, Robinson G, Struhl K, Spiegelman B . 1992 Genes Dev. 6: 1799–1809
Papavassiliou A, Treier M, Bohmann D . 1995 EMBO J. 14: 2014–2019
Perez S, Vial E, van Dam H, Castellazzi M . 2001 Oncogene 20: 1135–1141
Ransone L, Visvader J, Wamsley P, Verma I . 1990 Proc. Natl. Acad. Sci. USA 87: 3806–3810
Saez E, Rutberg S, Mueller E, Oppenheim H, Smoluk J, Yuspa S, Spiegelman B . 1995 Cell 82: 721–732
Sassone-Corsi P, Sisson J, Verma I . 1988 Nature 334: 314–319
Schreiber M, Poirier C, Franchi A, Kurzbauer R, Guenet J, Carle G, Wagner E . 1997 Oncogene 15: 1171–1180
Schuermann M, Hunter J, Hennig G, Muller R . 1991 Nucleic Acids Res. 19: 739–746
Schuur ER, Parker EJ, Vogt PK . 1993 Cell Growth Differ. 4: 761–768
Smeal T, Angel P, Meek J, Karin M . 1989 Genes Dev. 3: 2091–2100
Smeal T, Binetruy B, Mercola D, Birrer M, Karin M . 1991 Nature 354: 494–496
Sonobe MH, Yoshida T, Muramaki M, Kameda T, Iba H . 1995 Oncogene 10: 689–696
Spence H, Johnston I, Ewart S, Fitzgerald U, Ozanne B . 2000 Oncogene 19: 1266–1276
Stein B, Angel P, van Dam H, Ponta H, Herrlich P, van der Eb A, Rahmsdorf HJ . 1992 Photochem. Photobiol. 55: 409–415
Stein B, Baldwin A, Ballard D, Greene W, Angel P, Herrlich P . 1993 EMBO J. 12: 3879–3891
Suzuki T, Murakami M, Onai N, Fukuda E, Hashimoto Y, Sonobe MH, Kameda T, Ichinose M, Miki K, Iba H . 1994 J. Virol. 68: 3527–3535
Talanian R, McKnight C, Kim P . 1990 Science 249: 769–771
Vallone D, Battista S, Pierantoni G, Fedele M, Casalino L, Santoro M, Viglietto G, Fusco A, Verde P . 1997 EMBO J. 16: 5310–5321
van Dam H, Duyndam M, Rottier R, Bosch A, de Vries-Smits L, Herrlich P, Zantema A, Angel P, van der Eb AJ . 1993 EMBO J. 12: 479–487
van Dam H, Huguier S, Kooistra K, Baguet J, Vial E, van der Eb AJ, Herrlich P, Angel P, Castellazzi M . 1998 Genes Dev. 12: 1227–1239
van Dam H, van der Eb A . 1994 In: The Fos and Jun Families of Transcription Factors CRC Press: Boca Raton, FL, USA pp. 261–273
van Dam H, Wilhelm D, Herr I, Steffen A, Herrlich P, Angel P . 1995 EMBO J. 14: 1798–1811
Vandel L, Montreau N, Vial E, Pfarr C, Binetruy B, Castellazzi M . 1996 Mol. Cell. Biol. 16: 1881–1888
Vandel L, Pfarr C, Huguier S, Loiseau L, Sergeant A, Castellazzi M . 1995 Oncogene 10: 495–507
Vial E, Castellazzi M . 2000 Oncogene 19: 1772–1782
Vial E, Perez S, Castellazzi M . 2000 Oncogene 19: 5020–5029
Vogt PK . 1994 In: The Fos and Jun Families of Transcription Factors CRC press: Boca Raton, FL, USA pp. 203–219
Wathelet M, Lin C, Parekh B, Ronco L, Howley P, Maniatis T . 1998 Mol. Cell 1: 507–518
Wisdom R . 1999 Exp. Cell Res. 253: 180–185
Wolfgang C, Liang G, Okamoto Y, Allen A, Hai T . 2000 J. Biol. Chem. 275: 16865–16870
Wolthuis R, Bos J . 1999 Curr. Opin. Genet. Dev. 9: 112–117
Zerfass K, Spitkovsky D, Schulze A, Joswig S, Henglein B, Jansen-Durr P . 1996 J. Virol. 70: 2637–2642
Zohn I, Symons M, Chrzanowska-Wodnicka M, Westwick J, Der C . 1998 Mol. Cell. Biol. 18: 1225–1235
Zoumpourlis V, Papassava P, Linardopoulos S, Gillespie D, Balmain A, Pintzas A . 2000 Oncogene 19: 4011–4021
Acknowledgements
H van Dam was supported by grants from the Royal Netherlands Academy of Arts and Sciences (KNAW), the EU Training and Mobility of Researchers Program (TMR CT96-0044), the Dutch Cancer Society (RUL 97/1405), the European Economic Community Biomedicine and Health Program (Biomed II BMH4 CT98-3505) and the Netherlands Organization for Scientific Research (NWO 901-02-221). M Castellazzi was supported by grants from the Association pour la Recherche sur le Cancer, from the Mutuelle Générale de l'Education Nationale, and from the European Economic Community Biomedicine and Health Program (Biomed II contract n° BMH4 CT98-3505).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Dam, H., Castellazzi, M. Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis. Oncogene 20, 2453–2464 (2001). https://doi.org/10.1038/sj.onc.1204239
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204239
Keywords
This article is cited by
-
Identification of small molecules capable of enhancing viral membrane fusion
Virology Journal (2023)
-
Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ
Nature Communications (2023)
-
Prolonged FOS activity disrupts a global myogenic transcriptional program by altering 3D chromatin architecture in primary muscle progenitor cells
Skeletal Muscle (2022)
-
Identification and validation of core genes as promising diagnostic signature in hepatocellular carcinoma based on integrated bioinformatics approach
Scientific Reports (2022)
-
Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer
Breast Cancer Research (2020)